The REPIASA brand, founded in 2007 (Sweden), from 585 sister brands and 17478 competing brands. REPIASA is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. REPIASA is part of the Drug Manufacturers activity sector.